Showing results (1-10 of 16) with videos related to
Sort By:
Pageof 2
Cancer Biotherapy & Radiopharmaceuticals|November 3, 2009
Radioiodinated metaiodobenzylguanidine treatment of neuroendocrine tumors in adultsErnst J Postema, Alexander J B McEwanMolecular Imaging and Biology|November 6, 2023
Quantitative and Qualitative Assessment of Urinary Activity of 18F-Flotufolastat-PET/CT in Patients with Prostate Cancer: a Post Hoc Analysis of the LIGHTHOUSE and SPOTLIGHT StudiesPhillip H Kuo, Rick Hermsen, Ross Penny, et al.Comparative Medicine|March 21, 2002
Enhancing tumor implantation and growth rate of Ramos B-cell lymphoma in nude miceJeroen M B Manders, Ernst J Postema, Frans H M Corstens, et al.Cancer Metastasis Reviews|January 13, 2006
Antibody-guided radiation therapy of cancerManuel J Koppe, Ernst J Postema, Frits Aarts, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 17, 2020
Safety, Biodistribution, and Radiation Dosimetry of 18F-rhPSMA-7.3 in Healthy Adult VolunteersTuula Tolvanen, Kari Kalliokoski, Simona Malaspina, et al.Molecular Imaging and Biology|March 28, 2009
A randomised controlled trial assessing the effect of oral diazepam on 18F-FDG uptake in the neck and upper chest regionMarieke G G Sturkenboom, Otto S Hoekstra, Ernst J Postema, et al.European Journal of Nuclear Medicine and Molecular Imaging|May 12, 2009
Initial results of hypoxia imaging using 1-alpha-D: -(5-deoxy-5-[18F]-fluoroarabinofuranosyl)-2-nitroimidazole ( 18F-FAZA)Ernst J Postema, Alexander J B McEwan, Terence A Riauka, et al.Cancer Biotherapy & Radiopharmaceuticals|September 25, 2003
Biodistribution of 131I-, 186Re-, 177Lu-, and 88Y-labeled hLL2 (Epratuzumab) in nude mice with CD22-positive lymphomaErnst J Postema, Cathelijne Frielink, Wim J G Oyen, et al.European Journal of Nuclear Medicine and Molecular Imaging|April 13, 2021
Kinetic analysis and optimisation of 18F-rhPSMA-7.3 PET imaging of prostate cancerSimona Malaspina, Vesa Oikonen, Anna Kuisma, et al.Cancer Biotherapy & Radiopharmaceuticals|August 22, 2006
Targeting of biliary cancer with radiolabeled chimeric monoclonal antibody CG250Baudewijn W Hendrickx, Cees J A Punt, Otto C Boerman, et al.Pageof 2